483
Apitoria Pharma Private LimitedFDA 483 - Apitoria Pharma Private Limited - December 17, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
Aptoria Pharma Private Limited, Unit-V, located in Patancheru Mandal, India, received an FDA Form 483 citing significant deficiencies. The inspection revealed inadequate validation of aseptic processes for sterile drug substances, including issues with media fill studies and disinfectant efficacy. Additionally, the firm failed to conduct annual visual examinations of reserve samples for deterioration.
Open in Dashboard
ID · d3d1e57d-fbf0-4284-8804-4a4b14ac22c8